Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Mechanisms of Personalized tACS Targeting Anhedonia in Late-Life Depression

NCT07637773 is registered in ClinicalTrials.gov with Jie Li as lead sponsor.

NCT NCT07637773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07637773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Mechanisms of Personalized tACS Targeting Anhedonia in Late-Life Depression
Lead sponsor
Jie Li
Phase
Not applicable
Overall status
Recruiting
Start date
March 16, 2026
Completion date
December 31, 2027
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anhedonia, late-life depression